Navigation Links
DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment
Date:6/15/2010

cemic control.(vi,vii)

About BYETTA® (exenatide) injection

BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone glucagon-like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain.

BYETTA is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes mellitus, when used with a diet and exercise program. BYETTA is not insulin and should not be taken instead of insulin. BYETTA is not recommended to be taken with insulin. BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis.

BYETTA provides sustained A1C control and low incidence of hypoglycemia when used alone or in combination with metformin or a thiazolidinedione, with potential weight loss. BYETTA is not a weight-loss product. BYETTA was approved in April 2005 and has been used by more than one million patients since its introduction. See important safety information below. Additional information about BYETTA is available at www.BYETTA.com.

Important Safety Information for BYETTA® (exenatide) injection

Based on post-marketing data, BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. The risk for getting low blood sugar is higher if BYETTA is taken with another medicine that can cause low blood s
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Kline Study: Better Brushing Habits Boost European Oral Care Sales
4. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
5. NASA study will help stop stowaways to Mars
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
9. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
10. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
11. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- Aridis ... been reached with Switzerland -based ... anti-infective human monoclonal antibody (mAb) products, and technologies. ... mAb products for treatment of infections by common ... Staphylococcus aureus , Pseudomonas aeruginosa , ...
(Date:5/17/2013)... Canada (PRWEB) May 17, 2013 The ... understanding complex biological systems that can help predict the ... speaker Dr. Sergey Stepaniants, Head of Computational Biology at ... computational biology tools to ensure high-quality genomics when used ... can be applied to complex data sets to identify ...
(Date:5/17/2013)... May 17, 2013 IAC Industries wants to ... start up laboratory needing to set up and furnish a ... a larger facility within a year’s time. How does a ... the laboratory is temporary? What is efficient and cost-effective? ... workstations from IAC Industries. The planners at DisperSol determined that ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 ... Barbara A. Myers, CAE, to the newly created ... her new role, Myers will be responsible for ... and production strategies, advancing the Society’s Member-led and ... and continuing to refine organizational, membership and product ...
Breaking Biology Technology:Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2
... Life Sciences Greenhouse (PLSG), the organization providing capital investments ... the region,s life sciences enterprises, issued this statement through ... announcing the first close of the PLSG ... million. The Accelerator Fund is being managed ...
... A number of new ventures, funded with millions of dollars ... to produce biodiesel, jet fuel and other biofuels. Many of ... their photosynthetic algae, which as a side effect could help ... fossil fuel CO2 to grow algae is that it can ...
... 2011 Sutro Biopharma, a biopharmaceutical company developing ... properties, today announced that the company has entered ... research, development and commercialization of novel peptide-based therapeutics. ... Sutro Biopharma will receive an upfront payment of ...
Cached Biology Technology:Pittsburgh Life Sciences Greenhouse Announces the First Close of the PLSG Accelerator Fund LLC at $5 Million 2Algae Biofuel Spin-Off: Safer New Foods That Can Prevent Genetic Damage 2Algae Biofuel Spin-Off: Safer New Foods That Can Prevent Genetic Damage 3Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics 2
(Date:5/17/2013)... study finds human-caused climate change may have little ... a host of recent studies that predict their ... The findings, which appear in the journal ... survival of a creature thought to be doomed: ... cold-blooded animals, especially forest lizards, will be hard ...
(Date:5/17/2013)... team of scientists using a new X-ray method recorded ... frog embryo in greater detail than ever before., This ... and the search for new treatments for genetic diseases., ... Technologie in Germany, in collaboration with the Advanced Photon ... Laboratory, released the most precise depiction ever of the ...
(Date:5/16/2013)... to Research Careers) Program has announced the travel ... Annual Meeting in San Francisco, CA from June ... the entry of students, postdoctorates and scientists from ... science community and to encourage the participation of ... , Awards are given to poster/platform presenters and ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2New X-ray method shows how frog embryos could help thwart disease 2
... most famous faux pas of exploration, Columbus set sail for ... European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, set out ... reactions inside cells that bind to RNA, they too ... bind to RNA more than half as many as ...
... FARMINGTON, Conn., May 31, 2012 /PRNewswire-iReach/ -- ... insight into the complex but lucrative world of embryonic ... these excellent products, Global Information Inc is offering our ... their purchase, as well as a copy of BioInformant,s ...
... dilemmas posed by new technologies and medical choices, using 60 cases ... science. , This eminently readable book takes it one case at ... of 21st century medicine while giving the reader an informed basis ... Should we test and modify our genes? , How much is ...
Cached Biology News:The cell's 'New World' 2Navigating the Patent Minefield of Embryonic Stem Cell Product Development; Free Kindle Fire Tablet and Research Database with Purchase 2Navigating the Patent Minefield of Embryonic Stem Cell Product Development; Free Kindle Fire Tablet and Research Database with Purchase 3
IHC detection kit for PCNA in cells and tissues...
... The NEW HandyStep electronic from ... repeat pipetting. It is the only ... most standard syringe tips, including BRAND ... Combi-Tips Plus, Fisherbrand Dispenser Tips,and VWRbrand ...
... System is ideal for both radioactive and ... System: Provides five pre-mixed nucleotide solutions ... Yields >10 8 cpm/g control DNA ... monitor the performance of the system ...
... The LAB PAL label printer is portable, ... and efficient. Portable/Handheld Easy to ... Pre-programmed vial and slide sizes ... Affordable-every tech needs one Serialization ...
Biology Products: